Medical News Blog Information

Melanoma rates have doubled over the past 30 years, say CDC

The report also reveals that if no additional skin cancer prevention efforts are made at a community level, rates will continue to rise over the next 15 years; in 2030, there would be 112,000 new cases of melanoma diagnosed.
"The rate of people getting melanoma continues to increase every year compared to the rates of most other cancers, which are declining," says Dr. Lisa Richardson, director of the Division of Cancer Prevention and Control at the Centers for Disease Control and Prevention (CDC).
"If we take action now," she adds, "we can prevent hundreds of thousands of new cases of skin cancers, including melanoma, and save billions of dollars in medical costs."
To reach their findings, the CDC analyzed 2011 melanoma incidence and mortality data, using the information to estimate melanoma incidence and mortality rates and the cost of treatment for newly diagnosed cases over the next 15 years.
In addition, the CDC estimated the number of melanoma diagnoses and deaths that could be averted if a comprehensive skin cancer prevention program was implemented.

The report reveals that in 2011, 65,647 cases of invasive melanoma were diagnosed in the US and 9,128 melanoma deaths occurred.
Overall, melanoma deaths have remained stable since 1982, according to the report, with the death rate standing at 2.7 per 100,000 in 2011.
However, rates of new melanoma cases have doubled over the past 3 decades. The report reveals the number of melanoma cases stood at 22.7 per 100,000 in 2011, compared with 11.2 per 100,000 in 1982.
The report reveals that unless additional skin cancer interventions are adopted, melanoma rates will continue to rise, with around 112,000 new cases projected to be diagnosed in 2030. In addition, the cost of treating melanoma would rise by 252.4%, from $457 million in 2011 to $1.6 billion in 2030.
According to the report, however, implementing a comprehensive skin cancer prevention program could prevent around 20% of melanoma cases between 2020 and 2030 - the equivalent to around 21,000 annually.
What is more, implementing such a program could save around $2.7 billion on melanoma treatment costs between 2020 and 2030 - the equivalent to around $250 million a year.
Skin cancer is the most common form of cancer in both men and women in the US. While non-melanoma skin cancers make up the vast majority of cases, melanoma causes the most skin cancer deaths.
Melanoma is a cancer that begins in the melanocytes - the cells that produce the pigment melanin, which gives the skin its tan or brown color.
A major risk factor for melanoma and other skin cancers is exposure to ultraviolet (UV) radiation from the sun, as well as tanning beds and sun lamps. UV rays damage the DNA of skin cells, which can impair genes that control the growth and division of skin cells, causing the cells to become cancerous.
According to the report, more than 90% of melanomas in the US are caused by UV exposure.
As such, the CDC cite reducing UV exposure and increasing sun protection as major strategies for reducing melanoma rates going forward.
Such strategies can be achieved through community-wide programs, according to the CDC, which involve education on the risks of UV exposure, mass media campaigns and policy changes to increase skin protection.
Employers, child care centers, schools and colleges also play a vital role in skin cancer prevention, say the CDC. They can provide their employees or students with shaded areas and sun-protective clothing, for example, and discourage indoor tanning.
In addition, the CDC stress that we should all ensure we protect ourselves against the potentially harmful effects of UV exposure.
Credit medicalnewstoday.com



First steps taken for regenerating whole limbs

More than 1.5 million Americans have lost a limb. Prosthetic limbs have greatly advanced in function and appearance, but the authors of the new paper acknowledge that the devices still have many limitations.
Some patients over the past 20 years have received hand transplants from donors, but this procedure comes attached with lifelong risks from immunosuppressive therapy.
This problem could be solved by using the patient's own progenitor cells to regenerate the tissue for a new limb - rather than rely on a donor - but an appropriate matrix or scaffold has yet to be devised on which scientists would be able to grow the new tissue.
"The composite nature of our limbs makes building a functional biological replacement particularly challenging," explains senior author Dr. Harald Ott, of the Massachusetts General Hospital Department of Surgery and the Center for Regenerative Medicine.
Credit By medicalnewstoday.com

Is diabetes protective against amyotrophic lateral sclerosis?

A study of patients in Denmark suggests that type 2 diabetes may be associated with a reduced risk for the fatal neurodegenerative disease amyotrophic lateral sclerosis (ALS), according to an article published online by JAMA Neurology.

Recent reports have suggested a protective association between vascular risk factors, such as obesity or higher body mass index (BMI), higher cholesterol levels and hyperlipidemia with ALS incidence and survival. Patients with type 2 diabetes have, on average, higher BMI, elevated blood lipid levels and defective energy metabolism. However, the association between diabetes and ALS has not been widely explored.
Marianthi-Anna Kioumourtzoglou, Sc.D., of the Harvard T.H. Chan School of Public Health, Boston, and coauthors, examined the association between diabetes, obesity and ALS using data from Danish National Registers for 3,650 patients diagnosed with ALS between 1982 and 2009. The average age at diagnosis was 65.4 years. They were compared with 365,000 healthy control patients.

Toxins from bacteria could cause type 2 diabetes

A new study suggests that prolonged exposure to toxins produced from certain bacteria could cause type 2 diabetes.

Microbiologists from the University of Iowa observed that rabbits developed symptoms of type 2 diabetes, such as insulin resistance and glucose tolerance, following exposure to a toxin produced by Staphylococcus aureus (staph) bacteria.

A previous study by the team, led by Patrick Schlievert, PhD, professor and DEO of microbiology at the UI Carver College of Medicine, found that the immune system is disrupted by toxins produced by all strains of bacteria, known as superantigens.

The team's most recent study on rabbits coincided with examining staph colonisation levels of four patients with diabetes. The team believe superantigen exposure among people heavily colonised by staph is comparable to the superantigen doses that led to rabbits developing symptoms of diabetes.

Synjardy approved for type 2 diabetes treatment in the European Union

Synjardy, a new single-pill combination therapy, has been approved by the European Commission to treat adults with type 2 diabetes.
Syndardy is intended to improve blood glucose control alongside diet and exercise. It combines a sodium glucose cotransporter 2 (SGLT2), metformin hydrochloride (HCI) andempagliflozin, which was approved in the European Union in May 2014.

The drug is made by Eli Lilly and Company and Boehringer Ingelheim for type 2 patients whose blood sugar levels are either inadequately controlled by the maximum dose of metformin alone, or metformin alongside other glucose-lowering products.


Patients who are being treated with empagliflozin and metformin as separate tablets will also be eligible for Synjardy treatment.

Could diabetes protect against ALS?

The study, published in JAMA Neurology, set out to examine the association between diabetes- and obesity-related hospital admissions and the risk of a diagnosis with ALS.
The study "observed a significantly protective association with diabetes, but not obesity, on risk of ALS."
Marianthi-Anna Kioumourtzoglou, ScD, of the Harvard T.H. Chan School of Public Health in Boston, MA, conducted the study with coauthors, using data from Danish national registers for 3,650 patients diagnosed with ALS between 1982 and 2009.
sugar cubes and insulin needle

The average age at diagnosis was 65.4 years and the patients were compared with 365,000 healthy controls. Some 9,294 patients were identified as having diabetes, 55 of whom were subsequently diagnosed with ALS.

The authors say the findings are in agreement with previous reports of a protective association between vascular risk factors and ALS. They conclude:
"We conducted a nationwide, population-based study and observed an overall protective association between diabetes and ALS diagnosis, with the suggestion that type 2 diabetes is protective and type 1 diabetes is a risk factor.
"Although the mechanisms underlying this association remain unclear, our findings focus further attention on the role of energy metabolism in ALS pathogenesis."

Rare but fatal disease

Motor neuron diseases are progressive neurological disorders in which motor neurons - the cells that control the essential voluntary muscle activity allowing us to speak, walk, breathe and swallow - are destroyed.
ALS is the most common of these conditions - also known as classical motor neuron disease or Lou Gehrig's disease(American baseball player Lou Gehrig died of the disease in 1941), it is ultimately a fatal disorder that disrupts signals to all voluntary muscles.
Background evidence cited in the paper says around half of patients with ALS - which is rare, having an incidence rate of between 1.5 and 2.5 for every 100,000 people in the population every year - die within 3 years of its onset.
ALS was the subject of appeals for fundraising and greater awareness in the summer of 2014 - when the ice bucket challenge swept through social media.

Several possibilities if the link is causal

The latest study is a retrospective, population-based one, looking back over data to find links, so it was not of aprospective design that might have proven cause-and-effect links.
The authors discuss the potential etiology of the link, however: "If the protective association with diabetes results from some causal association with an aspect of diabetes rather than as a result of correlation with something else, then several possibilities could be surmised."
Possibilities discussed include that diabetes medications may be protective against ALS, metabolic factors resulting from diabetes could have a role, or that high concentrations of uric acid that have been associated with diabetes have also been linked to "lower incidence of other neurodegenerative diseases and prolonged survival in ALS."

Obesity may lead to type 2 diabetes via bacteria

There is a strong link between obesity and type 2 diabetes, where fat cells contribute to development of the disease by changing metabolism and chronic inflammation. Now, a new study suggests that obesity's effect on the microbiome - the ecosystem of bacteria and other microbes that live on and in our bodies and affect our health - could be involved.

overweight man on treadmill

The study, published in the journal mBio, adds to growing evidence about the role of bacteria and viruses in causing noninfectious diseases, such as cervical cancer (human papillomavirus) and stomach ulcers (H. pylori bacteria).

Microbiologists at the University of Iowa (UI) found that when rabbits are chronically exposed to a toxin produced by Staphylococcus au

Like Us

Blog Archive